Normal view MARC view ISBD view

Mittelman, Moshe

The lower risk MDS patient at risk of rapid progression. [electronic resource] - Leukemia research Dec 2010 - 1551-5 p. digital

Publication Type: Journal Article; Review

ISSN: 1873-5835

Standard No.: 10.1016/j.leukres.2010.05.023 doi

Subjects--Topical Terms:
Age Factors
Antigens, Differentiation--blood
Antineoplastic Agents--therapeutic use
Caspase 3--biosynthesis
Chromosome Aberrations
Cyclin-Dependent Kinase Inhibitor p15--biosynthesis
Cytokines--therapeutic use
DNA Methylation--genetics
Erythrocyte Transfusion
Female
Ferritins--blood
Fibrosis
Gene Expression Regulation--genetics
Humans
Immunosuppression Therapy
Immunosuppressive Agents--therapeutic use
Inhibitor of Apoptosis Proteins
Lenalidomide
Leukocyte Count
Lipoproteins, LDL--blood
Lymphoid Enhancer-Binding Factor 1--biosynthesis
Male
Microtubule-Associated Proteins--biosynthesis
Mutation
Myelodysplastic Syndromes--diagnosis
Platelet Count
Prognosis
Proto-Oncogene Proteins--biosynthesis
Proto-Oncogene Proteins c-bcl-2--biosynthesis
Receptor Protein-Tyrosine Kinases--biosynthesis
Risk Factors
Sex Factors
Survivin
Thalidomide--analogs & derivatives
alpha Catenin--biosynthesis
Axl Receptor Tyrosine Kinase